Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Head and/or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Testing effectiveness (Phase 2)Study completedNCT05597839
What this trial is testing

Study of DF9001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT00886132
What this trial is testing

Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Who this might be right for
Adenoid Cystic CarcinomaSalivary Gland Cancer
University Health Network, Toronto 14
Not applicableNot Yet RecruitingNCT07533357
What this trial is testing

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Fudan University 158
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06780111
What this trial is testing

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 298
Testing effectiveness (Phase 2)Study completedNCT00768664
What this trial is testing

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Neoplasms
Pfizer 69
Testing effectiveness (Phase 2)Temporarily pausedNCT05929664
What this trial is testing

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Who this might be right for
Locally Advanced Basal Cell CarcinomaBasal Cell Carcinoma
Thomas Jefferson University 70
Testing effectiveness (Phase 2)Study completedNCT01443065
What this trial is testing

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
UNICANCER 162
Testing effectiveness (Phase 2)UnknownNCT02216916
What this trial is testing

Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy

Who this might be right for
HNSCC
Yonsei University 49
Early research (Phase 1)Not Yet RecruitingNCT05582590
What this trial is testing

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Who this might be right for
Oropharyngeal CancerHuman Papilloma VirusHead and Neck Cancer+8 more
NexImmune Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Testing effectiveness (Phase 2)Ended earlyNCT00239200
What this trial is testing

Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus
University of Michigan Rogel Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03085719
What this trial is testing

Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05126719
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Lepu Biopharma Co., Ltd. 238
Testing effectiveness (Phase 2)Study completedNCT00095628
What this trial is testing

SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+19 more
National Cancer Institute (NCI) 21
Not applicableStudy completedNCT00836992
What this trial is testing

Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+8 more
Mayo Clinic 144
Testing effectiveness (Phase 2)UnknownNCT02520453
What this trial is testing

Adjuvant Durvalumab for Esophageal Cancer

Who this might be right for
Esophageal Cancer
Samsung Medical Center 86
Testing effectiveness (Phase 2)Ended earlyNCT04916002
What this trial is testing

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+3 more
Regeneron Pharmaceuticals 77
Testing effectiveness (Phase 2)Study completedNCT01711541
What this trial is testing

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaStage IVA Oropharyngeal Carcinoma AJCC v7Stage IVB Oropharyngeal Carcinoma AJCC v7
National Cancer Institute (NCI) 24
Next Page